Adenosine inhibits the release of arachidonic acid in activated human peripheral mononuclear cells. A proposed model for physiologic and pathologic regulation in systemic lupus erythematosus

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 972-980

  Sipka, Sándor ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Adenosine; Arachidonic acid; Phopholipase A2; Protein kinase C; Systemic lupus erythematosus (SLE)

Indexed keywords

ADENOSINE; ARACHIDONIC ACID; CALCIUM ION; INTERLEUKIN 1BETA; IONOPHORE; PHORBOL ESTER; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP IV; PROTEIN KINASE C;

CYTOKINE PRODUCTION; CYTOSOL; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MONOCYTE; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADENOSINE; ARACHIDONIC ACID; HUMANS; INTERLEUKIN-1BETA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, BIOLOGICAL; MONOCYTES, ACTIVATED KILLER; PROTEIN KINASE C;

EID: 79958175939     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.88     Document Type: Short Survey

References (38)

1. Kumar, V. and Sharma, A. (2009) Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur. J. Pharmacol. 616, 7-15.
2. Cronstein, B.N. (1994) Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76, 5-13.
3. Manjunath, S. and Akhare, M. (2009) Adenosine and adenosine receptors: newer therapeutic perspective. Ind. J. Pharmacol. 4, 97-105.
4. Sipka, S., Seres, T., Dinya, Z., Szekanecz, Z., Szentmiklósi, J., Bodolay. E., and Szegedi, Gy. (1995) Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms. Mediators Inflamm. 4, 454-455. (Pubitemid 26019451)
5. Haskó, G., Linden, J., Cronstein, B., and Pacher, P. (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7, 759-770.
6. Bodnár, Zs., Keresztes, T., Kovács, I., Hajdu, Z., Boissonneault, G.A., and Sipka, S. (2010) Increased serum adenosine and interleukin 10 level as new laboratory markers of increased intra-abdominal pressure. Langenbecks Arch. Surg. 395, 969-972.
7. Haskó, G. and Cronstein, B.N. (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25, 33-39. (Pubitemid 38032805)
8. Ernst, P.B., Garrison, J.C., and Tompson, LF. (2010) Much Ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J. Immunol. 185, 1993-1998.
9. Antonioli, L., Fornai, M., Colucci, R., Ghisu, N., Tuccori, M., Tacca, M.D., and Blandizzi, C. (2008) Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflamm. Bowel Dis. 14, 566-574. (Pubitemid 351571838)
10. Noji, T., Karasawa, A., and Kusaka, H. (2004) Adenosine uptake inhibitors. Eur. J. Pharmacol. 496, 1-16. (Pubitemid 38829385)
11. Iwaki-Egawa, S., Xamamoto, T., and Watanabe, Y. (2006) Human plasma adenosine deaminase 2 is secreted by activated monocytes. Biol. Chem. 387, 319-321.
12. 2 structure/function, mechanism and signaling. J. Lipid Res. 50, S237-242.
13. Glew, R.H. (2006) Lipid metabolism II. Pathways of metabolism of special lipids. In Textbook of Biochemistry with Clinical Correlations. 6th ed. Devlin, T.M., Ed. Wiley-Liss, Hoboken, NJ. pp. 730-738.
14. Sellmayer, A., Obermeier, H., Danesch, U., Aepfelbacher, M., and Weber, P.C. (1996) Arachidonic acid increases activation of NADPH oxidase in monocytic U937 cells by accelerated translocation of p47-phox and co-stimulation of protein kinase C. Cell Signal. 8, 397-402. (Pubitemid 26366420)
15. 2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue derived mesenchymal stromal cells. Exp. Cell Res. 316, 3109-3123.
16. Sipka, S., Kovács, I., Szántó, S., Szegedi, G., Brúgós L., Bruckner, G., and Szentmiklósi, A.J. (2007) Adenosine inhibits the release of arachidonic acid and its metabolites (AAM) in activated human peripheral mononuclear cells. Inflamm. Res. 56, 486-472.
17. Chang, J., Gilman, S.C., and Lewis, A.J. (1986) Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL-1 action. J. Immunol. 136, 1283-1287. (Pubitemid 16156229)
18. Wu, T., Han, C., and Shelhamer, J.H. (2004) Involvement of p38 and p42/44 MAP kinases and protein kinase C in the interferon-gamma and interleukin 1 alpha induced phosphorylation of 85 kDa cytosolic phospholipase A2 in primary epithelial cells. Cytokine 25, 11-20. (Pubitemid 37543693)
19. + helper cells and regulates Helicobacter induced gastritis and bacterial persistence. Mucosal Immunol. 2, 232-242.
20. Sipka, S., Kovács, I., Szántó. S., Szegedi, G., Brugós, L., Bruckner, G., et al. (2005) Adenosine inhibits the release of interleukin 1β in activated human peripheral mononuclear cells. Cytokine 31, 258-263. (Pubitemid 41097361)
21. Flamand, N., Boudreault, S., Picard, S., Austin, M., Surette, M.E., Plante, H., Krump, E. et al. (2000) Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils. Am. J. Respir. Crit. Care Med. 161, S88-S94. (Pubitemid 30129423)
22. van Waeg, G. and Van den Berghe, G. (1991) Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase. J. Clin. Invest. 87, 305-312.
23. Moser, G.H., Schrader, J., and Deussen, A. (1989) Turnover of adenosine in plasma of human and dog blood. Am. J.Physiol. 256, C799-C806.
24. 2 correlate with lymphocyte maturation. J. Immunol. 156, 2054-2061.
25. Sipka, S., Szántó, S., Szu{combining double acute accent}cs, K., Kovács, I., Kiss, E., Antal-Szalmás, P., Lakos, G., Aleksza, M., Illés, Á., Gergely, P., and Szegedi, Gy. (2001) Decreased arachidonic acid release in peripheral monocytes of patients with systemic lupus erythematosus. J. Rheumatol. 28, 2012-2017. (Pubitemid 32803778)
26. Bíró, T., Griger, Z., Kiss, E., Papp, H., Aleksza, M., Kovács, I., Zeher, M., Bodolay, E., Csépány, T., Szu{combining double acute accent}cs, K., Gergely, P., Szegedi, Gy., and Sipka, S. (2004) Abnormal cell-specific expressions of certain protein kinase C isoenzymes in peripheral mononuclear cells of patients with systemic lupus erythematosus: effect of corticosteroid application. Scand. J. Immunol. 60, 421-428.
27. Griger, Z., Páyer, E., Kovács, I., Tóth, B.I., Kovács, L., Sipka, S., and Bíró T. (2007) Protein kinase C-β and -δ isoenzymes promote arachidonic acid production and proliferation of MonoMac-6 cells. J. Mol. Med. 85, 1031-1042. (Pubitemid 47282793)
28. 2. Immunology 118, 343-352.
29. + regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity 40, 521-528.
30. 2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J. Biol. Chem. 285, 27571-27580.
31. Kontny, E., Kurowska, M., Szczepanska, K., and Maslinski, W. (2000) Rottlerin, a PKC isoenzyme selective inhibitor, affects signaling events and cytokine production in human monocytes. J. Leukoc. Biol. 67, 249-258.
32. Andersen, L.S., Petersen, J., Svenson, M., and Bendtzen, K. (1999) Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE. Autoimmunity 30, 235-242. (Pubitemid 29484314)
33. Martinez, J. and Moreno, J.J. (1996) Influence of superoxide radical and hydrogen peroxide on arachidonic acid mobilization. Arch. Biochem. Biophys. 336, 191-198. (Pubitemid 26428233)
34. 1 adenosine receptor in porcine coronary smooth muscle cells. Vascul. Pharmacol. 39, 47-54.
35. 2 adrenoceptor activation. Neuorochem. Int. 51, 47-56.
36. Stancikova M., Lukac, J., Istok, R., Cristakki, G., and Rovensky, J. (1998) Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 16, 583-586. (Pubitemid 28439443)
37. Saghiri, R., Ghshghai, N., Movaseghi, S., Poursharifi, P., Jalifar, S., Bidhendi, M.A., Ghazizadeh, L., and Ebrahini- Rad, M. (2011) Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzyme pattern. Rheumatol. Int. (in press).
38. Aghdassi, E., Ma, D.W., Morrison, S., Hillyer, L.M., Clarke, S., Gladman, D.D., Urowitz, M.B., and Fortin, P.R. (2011) Alterations on circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. JPEN J. Parenter. Enteral Nutr. 35, 198-208.